Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Main Authors: | Zamora-Ros, R, Ferrari, P, González, C, Tjønneland, A, Olsen, A, Bredsdorff, L, Overvad, K, Touillaud, M, Perquier, F, Fagherazzi, G, Lukanova, A, Tikk, K, Aleksandrova, K, Boeing, H, Trichopoulou, A, Trichopoulos, D, Dilis, V, Masala, G, Sieri, S, Mattiello, A, Tumino, R, Ricceri, F, Bueno-de-Mesquita, H, Peeters, P, Weiderpass, E |
---|---|
Format: | Journal article |
Published: |
2013
|
Similar Items
-
Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
by: Zamora-Ros, R, et al.
Published: (2013) -
The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study.
by: Zamora-Ros, R, et al.
Published: (2013) -
Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study.
by: Zamora-Ros, R, et al.
Published: (2013) -
Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study
by: Zamora-Ros, R, et al.
Published: (2013) -
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
by: Kaaks, R, et al.
Published: (2014)